期刊文献+

胸腺五肽油包水型口服微乳的处方设计与评价 被引量:2

Formulation and characterization of water-in-oil microemulsions for oral delivery of thymopentin
下载PDF
导出
摘要 目的对胸腺五肽油包水(W/O)型口服微乳进行处方设计及评价。方法 Km值(Km=m乳化剂∶m助乳化剂)滴定法制备伪三元相图,考察油相、乳化剂、助乳化剂、Km值、温度和药物对W/O微乳区域面积和载水量的影响,求出W/O型微乳的最佳处方组合。结果物理化学性质稳定且W/O区域面积和载水量均较高的W/O型微乳的最佳处方组合为蒸馏水/豆磷脂/无水乙醇/辛癸酸三甘油酯(Km=1∶1),制备温度为室温(20±1)℃。根据最佳处方组合,将水溶性药物胸腺五肽溶于水相中,制备了含药微乳的伪三元相图。结论蒸馏水/豆磷脂/无水乙醇/辛癸酸三甘油酯(Km=1∶1)组合具有较大W/O区域面积和载水量,可成功地将水溶性肽类药物包载于水相,并可将其应用于口服药物传递载体。 Objective To formulate the water-in-oil microemulsions for oral delivery of thymopentin.Methods Effect of oil,emulsifier,coemulsifier,Km value,temperature and drug on the mass ratio of water loaded in water-in-oil microemulsions and the area sizes of water-in-oil microemulsions,was studied by constructing pseudo-ternary phase diagram using traditional Km titration,in order to get the best combination of various ingredients.Results Water/soybean lecithin/absolute ethanol/caprylic/capric triglyceride(Km equals one to one)was distillated at room temperature and a stable water-in-oil microemulsion formulation with a higher water content and area sizes of water-in-oil microemulsions was obtained.In addition,thymopentin was incorporated into the aqueous phase and then pseudo-ternary phase diagram of TP5-loaded water-in-oil(W/O)microemulsion with was constructed.Conclusions Microemulsions based on combinations of distilled water/soybean lecithin/absolute ethanol/caprylic/capric triglyceride(Km equals one to one)at room temperature have a higher water content and area sizes of water-in-oil microemulsions and is a potential carrier for oral delivery of peptides.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第8期599-604,共6页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(30672555)
关键词 肽类药物 油包水型微乳 Km值滴定法 伪三元相图 peptide drug water-in-oil microemulsion Km titration pseudo-ternary phase diagram
  • 相关文献

参考文献20

  • 1RAWAT M, SINGH D, SARAF S. Lipid carriers: a versatile delivery vehicle for proteins and peptides [ J ]. Yakugaku Zasshi, 2008,128 (2) : 269 - 280.
  • 2LAWRENCE M J, REES G D. Microemulsion-based media as novel drug delivery systems [ J ]. Adv Drug Deliv Rev,2000,45( 1 ) :89 - 121.
  • 3ROSANOHL C M. Microemulsion Systems[ M]. New York: Marcel Dekker, 1987:64 - 75.
  • 4CONSTANTINIDES P P. Lipid microemulsions for improving drug dissolution and oral absorption:physical and biopharmaceutical aspects [ J ]. Pharm Res, 1995,12(11) :1561 - 1572.
  • 5SARCIAUX J M, SADO P A. Using microemulsion formulation for drug delivery of therapeutic peptides [ J]. Int J Pharm, 1995,120:127 - 136.
  • 6SWENSON E C. Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity [ J ]. Adv Drag Deliv Rev, 1992,8:39 - 92.
  • 7CHENG M B, WANG J C, LI Y H, et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme [ J ]. J Control Release,2008,129( 1 ) :41 -48.
  • 8TARR B D,YALKOWSKY S H. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size[ J ]. Pharm Res, 1989,6 (1) :40-43.
  • 9RITSCHEL W A. Microemulsions for improved peptide absorption from the gastrointestinal tract [ J ]. Methods Find Exp Clin Pharmacol, 1991, 13 ( 3 ) : 205 - 220.
  • 10PAPADIMITRIOU V, PISPAS S, SYRIOUS S, et al. Biocompatible microemulsions based on limonene: formulation, structure, and applications [ J ]. Langmuir, 2008,24(7) :3380 - 3386.

同被引文献28

  • 1寇欣.微乳给药系统的研究进展[J].天津药学,2005,17(6):49-52. 被引量:24
  • 2Papadaiiteiou V, Pispas S, Syrious S, et a/.Biocompatible microemulsions based on limonene: formulation, struc- ture, and applications[J]. Langmuir, 2008,24 (7): 3 380.
  • 3Schechter RS.Microemulsions and related systems[M]. New York .. Marcel Dekker, 1998 : 1-200.
  • 4Peira E, Scolari P, Gasaco MR.Transdermal permeation of apomorphine through hairless mouse skin from micro- emulsion[J].Int JPharm, 2001,226( 1-2 ) : 47.
  • 5Ho HO, Hsiao CC, Sheu MT.Preparation of microemul- sions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs[J]. J Pharm Sci, 1996, 85 (2) : 138.
  • 6Shinoda K, Arakim M, Sadaghiani A, et al.Lecithin-based microemulsions: phase behavior and microstructure[J]. J Phys Chem , 1991,95(2) :989.
  • 7Binks BP, Meunier J, Langevin D.Characteristic sizes, film rigidity and interfacial tensions in microemulsion sys- tems[J]. Progr Colloid Polym Sci, 1989,79:208.
  • 8印晓星,扬帆.生物药剂学与药物动力学[M].北京:科学出版社,2009:180-195.
  • 9LIU K X,KATO Y,KAKU T,et al. Hydroxyprolylserinederivatives JBP923 and JBP 485 exhibit the antihepatitisactivities after gastrointestinal absorption in rats [ J]. JPharm Exp Ther,2000,294(2):510-515.
  • 10WU J J,WANG C Y,LIU Q,et al. Protective effect of JBP485 on Concanavalin A-induced hepatocyte toxicity inprimary cultured rat hepatocytes [J]. Eur J Pharm,2008,589(1-3):299-305.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部